Vir Biotechnology, Inc. Common Stock VIR
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-07T06:53:39.736Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-07T00:45:46.298331268Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-07T06:53:37.720251+00:00
Vir Biotechnology, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 10.66 | 100.0% | 16.0% | |||
| 25Δ | 14.06 | 90.3% | 16.4% | 11.01 | 102.9% | 13.9% |
| 30Δ | 13.70 | 88.3% | 14.1% | 11.33 | 108.9% | 12.8% |
| 35Δ | 13.34 | 85.4% | 11.8% | 11.64 | 114.9% | 11.6% |
| 40Δ | 12.99 | 82.8% | 9.5% | 11.96 | 120.8% | 10.5% |
| 45Δ | 12.74 | 86.0% | 8.6% | 12.25 | 114.6% | 8.9% |
| 50Δ | 12.49 | 89.2% | 7.7% | 12.54 | 106.4% | 7.3% |
| 55Δ | 12.24 | 92.3% | 6.8% | 12.83 | 98.2% | 5.7% |
| 60Δ | 11.98 | 95.3% | 5.9% | 14.30 | 182.5% | 8.0% |
| 65Δ | 11.69 | 94.6% | 4.9% | 14.93 | 181.6% | 6.6% |
| 70Δ | 11.41 | 93.9% | 4.0% | 15.48 | 172.3% | 5.2% |
| 75Δ | 11.12 | 93.2% | 3.1% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.66
- IV
- 100.0%
- B/E move
- 16.0%
25Δ
- Pseudo strike
- 14.06
- IV
- 90.3%
- B/E move
- 16.4%
- Pseudo strike
- 11.01
- IV
- 102.9%
- B/E move
- 13.9%
30Δ
- Pseudo strike
- 13.70
- IV
- 88.3%
- B/E move
- 14.1%
- Pseudo strike
- 11.33
- IV
- 108.9%
- B/E move
- 12.8%
35Δ
- Pseudo strike
- 13.34
- IV
- 85.4%
- B/E move
- 11.8%
- Pseudo strike
- 11.64
- IV
- 114.9%
- B/E move
- 11.6%
40Δ
- Pseudo strike
- 12.99
- IV
- 82.8%
- B/E move
- 9.5%
- Pseudo strike
- 11.96
- IV
- 120.8%
- B/E move
- 10.5%
45Δ
- Pseudo strike
- 12.74
- IV
- 86.0%
- B/E move
- 8.6%
- Pseudo strike
- 12.25
- IV
- 114.6%
- B/E move
- 8.9%
50Δ
- Pseudo strike
- 12.49
- IV
- 89.2%
- B/E move
- 7.7%
- Pseudo strike
- 12.54
- IV
- 106.4%
- B/E move
- 7.3%
55Δ
- Pseudo strike
- 12.24
- IV
- 92.3%
- B/E move
- 6.8%
- Pseudo strike
- 12.83
- IV
- 98.2%
- B/E move
- 5.7%
60Δ
- Pseudo strike
- 11.98
- IV
- 95.3%
- B/E move
- 5.9%
- Pseudo strike
- 14.30
- IV
- 182.5%
- B/E move
- 8.0%
65Δ
- Pseudo strike
- 11.69
- IV
- 94.6%
- B/E move
- 4.9%
- Pseudo strike
- 14.93
- IV
- 181.6%
- B/E move
- 6.6%
70Δ
- Pseudo strike
- 11.41
- IV
- 93.9%
- B/E move
- 4.0%
- Pseudo strike
- 15.48
- IV
- 172.3%
- B/E move
- 5.2%
75Δ
- Pseudo strike
- 11.12
- IV
- 93.2%
- B/E move
- 3.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 105.32% | |
| 90.73% | |
| 79.44% | |
| 88.73% | |
| 93.19% | |
| 97.11% | |
| 97.65% | |
| 86.38% | |
| 76.45% | |
| 85.97% |
Biotechnology
VKTX
Description unavailable
More →VNDA
Description unavailable
More →VOR
Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. The company is headquartered in…
More →VRDN
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. The company is headquartered in Boulder, Colorado.
More →VRTX
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
More →VSTM
Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in…
More →